Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma

Ji Hoon Kim, Joong Won Park, Dong Wook Koh, Woo Jin Lee, Chang Min Kim

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background/Aims: Treatment of patients with hepatocellular carcinoma (HCC) depends on the tumour extent and underlying liver function. Antiviral therapy with nucleoside/nucleotide analogues has been shown to be effective in improving the liver function of chronic hepatitis B (CHB) patients. We assessed whether lamivudine could induce biochemical and virological improvements in patients with hepatitis B virus-related HCC. Patients/Methods: Of 148 CHB patients treated with 100 mg/day lamivudine for at least 6 months, 80 had HCC (CHB/HCC group) and 68 did not (CHB group). Biochemical and virological parameters were serially monitored. Results: Compared with the CHB group, the CHB/HCC group was older, had higher male predominance, bilirubin levels and liver cirrhosis rate, and lower albumin and hepatitis B virus (HBV) DNA levels and hepatitis B e antigen (HBeAg) positivity (P < 0.05 each). The two groups showed similar cumulative rates of alanine aminotransferase normalization, HBV DNA seroconversion, HBeAg loss and viral breakthrough during 12 months of lamivudine treatment. After 12 months, the CHB/HCC group showed, relative to baseline, increased albumin levels (3.51 ± 0.5 vs. 3.72 ± 0.5mg/ml) and decreased ascites scores (1.63 ± 0.7 vs. 1.45 ± 0.6) and Child-Pugh scores (6.92 ± 1.9 vs. 6.02 ± 1.38) (P < 0.05 each). Conclusion: Lamivudine had comparable antiviral effects both in patients with CHB and CHB/HCC, and improved underlying liver function in the latter group. Treatment of HBV may increase the chance of curative treatments in patients with HBV-related HCC.

Original languageEnglish
Pages (from-to)203-207
Number of pages5
JournalLiver International
Volume29
Issue number2
DOIs
Publication statusPublished - 2009

Keywords

  • Chronic hepatitis B
  • Efficacy
  • Hepatocellular carcinoma
  • Lamivudine
  • Liver function

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma'. Together they form a unique fingerprint.

  • Cite this